Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Clinical trial NCT00655551 · COMPLETED

Trial details

NCT number: NCT00655551
Sponsor: UCB BIOSCIENCES, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Epilepsies Partial Onset Seizures

Start date: 2008-04-01
Primary completion: 2009-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.